在GP VI中介的血小板激活和前凝剂活动加剧了腹腔大动脉动脉瘤中的炎症和大动脉壁重塑
Tobias Feige1, Agnes Bosbach1, Kim J Krott1
1Department of Vascular and Endovascular Surgery (T.F., A.B., K.J.K., J.M., J.O., E.K., I.K., N.S., W.I., M.U.W., H.S., M.E.), University Hospital Duesseldorf, Heinrich-Heine University, Germany.
血小板糖蛋白VI (GP VI) 缺乏,通过减少炎症和改善大动脉壁重塑,防止腹腔大动脉动脉瘤 (AAA) 的发展和进展. 向GP VI可能为AAA患者提供一种新的抗血小板疗法.
科学领域:
- 心血管研究研究心血管研究
- 血管生物学 血管生物学
- 血小板生物学 血小板生物学
背景情况:
- 腹腔大动脉瘤 (AAA) 是一种致命的,与动脉样硬化相关的疾病,其特征是大动脉扩张和炎症.
- 血小板激活和前凝活性在AAA病原发生过程中至关重要,可能触发疾病发展.
- 血小板糖蛋白 (GP) VI在AAA开始和进展中的作用需要进一步研究.
研究的目的:
- 研究主要的血小板原受体GP VI对AAA底层的病理生理过程的影响.
- 评估GP VI作为AAA治疗点的潜力.
主要方法:
- 在小鼠中使用猪胰腺弹性酶 (PPE) 进行AAA诱导实验.
- 在小鼠中遗传删除GP VI以评估其保护作用.
- 对大动脉壁炎症,重塑标记物和细胞亡的分析.
- 在AAA患者中测量可溶性GP VI,纤维素,矩阵金属蛋白酶 (MMP) 和骨质红素 (OPN) 的血含量.
主要成果:
- 基因删除GP VI保护小鼠免受AAA发展,减少大动脉直径扩张和动脉瘤发生率.
- 缺少GP VI导致大动脉壁炎症减少,其特征是中性粒细胞和血小板透减少.
- 缺少GP VI改善了大动脉壁重塑,降低了MMP-2/9和OPN水平,增强了α-SMA含量,并降低了亡.
- 在GP VI缺乏的小鼠中观察到高密度/介质厚度和弹性质含量.
- 在AAA患者中,可溶性GP VI和纤维素水平可能作为潜在的早期检测生物标志物.
结论:
- 在AAA启动和进展中,GP VI起着重要作用.
- 用抗血小板治疗向GP VI可能是一个有希望的策略,以减少AAA的发展和进展.
- 针对GP VI的向治疗可能会保护AAA患者免受大动脉破裂.
更多相关视频
11:18Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
Published on: April 2, 2013
04:32A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
Published on: June 5, 2019
相关概念视频
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Clot Retraction and Fibrinolysis
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Inflammation
